RNAvision Platform for Rare Disease Research

About OmicsDiscoveries

OmicsDiscoveries is a Berlin-based biotech firm operating at the intersection of proteomics, genomics, and machine learning. The company has developed the RNAvision platform, a software-as-a-service solution that integrates RNA-seq data with clinical information to prioritize genetic variants and improve diagnostic yield for rare diseases. Its tools, including OUTRIDER, FRASER, and DROP, are research-validated and aim to convert variants of uncertain significance (VUS) into actionable findings. The company targets the research and molecular diagnostics markets, offering a bridge between advanced genomic research and clinical application.

Therapeutic Areas